X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12583) 12583
Book Chapter (24) 24
Magazine Article (10) 10
Book / eBook (7) 7
Publication (6) 6
Conference Proceeding (2) 2
Dissertation (2) 2
Book Review (1) 1
Government Document (1) 1
Newsletter (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
fluoroquinolones (7297) 7297
humans (7101) 7101
pharmacology & pharmacy (6001) 6001
microbiology (5081) 5081
microbial sensitivity tests (4609) 4609
anti-bacterial agents - pharmacology (4135) 4135
infectious diseases (3223) 3223
animals (3135) 3135
fluoroquinolones - pharmacology (3094) 3094
anti-infective agents - pharmacology (2998) 2998
male (2812) 2812
ciprofloxacin (2556) 2556
female (2481) 2481
drug resistance, bacterial (1804) 1804
adult (1654) 1654
antibiotics (1586) 1586
ciprofloxacin - pharmacology (1525) 1525
levofloxacin (1442) 1442
quinolones (1413) 1413
middle aged (1411) 1411
fluoroquinolone (1351) 1351
fluoroquinolone resistance (1263) 1263
moxifloxacin (1232) 1232
quinolones - pharmacology (1232) 1232
mutation (1171) 1171
anti-bacterial agents - therapeutic use (1130) 1130
escherichia-coli (1127) 1127
resistance (1114) 1114
pharmacokinetics (1109) 1109
bacteria (1106) 1106
aged (1073) 1073
susceptibility (1068) 1068
escherichia coli - drug effects (1050) 1050
drug resistance (964) 964
antimicrobial resistance (949) 949
anti-infective agents - therapeutic use (929) 929
anti-infective agents - pharmacokinetics (903) 903
infections (881) 881
drug resistance, microbial (877) 877
fluoroquinolones - therapeutic use (837) 837
biochemical phenomena, metabolism, and nutrition (823) 823
dna gyrase - genetics (798) 798
streptococcus pneumoniae - drug effects (797) 797
drug resistance in microorganisms (791) 791
research article (786) 786
ofloxacin - pharmacology (785) 785
dna gyrase (763) 763
analysis (760) 760
drug resistance, bacterial - genetics (746) 746
bacterial infections and mycoses (742) 742
in-vitro (709) 709
mutations (695) 695
adolescent (694) 694
prevalence (691) 691
dose-response relationship, drug (689) 689
mice (689) 689
antimicrobial agents (684) 684
veterinary sciences (669) 669
staphylococcus aureus - drug effects (668) 668
streptococcus-pneumoniae (668) 668
strains (658) 658
anti-bacterial agents - administration & dosage (642) 642
bacteria - drug effects (635) 635
ofloxacin (622) 622
fluoroquinolones - administration & dosage (618) 618
antibacterial agents (613) 613
fluoroquinolones - pharmacokinetics (605) 605
antibiotic-resistance (592) 592
anti-infective agents - administration & dosage (589) 589
research (580) 580
anti-bacterial agents - pharmacokinetics (575) 575
administration, oral (572) 572
staphylococcus-aureus (572) 572
bacterial proteins - genetics (569) 569
drug resistance, multiple, bacterial (552) 552
quinolines - pharmacology (552) 552
immunology (548) 548
infection (518) 518
mechanisms (518) 518
quinolone resistance (518) 518
naphthyridines - pharmacology (515) 515
aged, 80 and over (514) 514
gram-negative bacteria - drug effects (514) 514
escherichia coli - genetics (509) 509
area under curve (497) 497
gatifloxacin (496) 496
pharmacology (495) 495
time factors (490) 490
chemistry, medicinal (487) 487
treatment outcome (483) 483
mycobacterium tuberculosis - drug effects (479) 479
health aspects (477) 477
enrofloxacin (476) 476
antibiotic resistance (468) 468
quinolone (468) 468
risk factors (460) 460
internal medicine (459) 459
pseudomonas aeruginosa - drug effects (459) 459
dna topoisomerase iv - genetics (452) 452
gram-positive bacteria - drug effects (451) 451
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12233) 12233
Japanese (303) 303
Spanish (106) 106
French (105) 105
Russian (74) 74
Chinese (73) 73
Portuguese (33) 33
German (28) 28
Italian (14) 14
Polish (14) 14
Romanian (8) 8
Turkish (6) 6
Dutch (4) 4
Korean (3) 3
Slovak (3) 3
Croatian (2) 2
Czech (2) 2
Finnish (1) 1
Hungarian (1) 1
Serbian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet infectious diseases, ISSN 1473-3099, 2013, Volume 13, Issue 4, pp. 328 - 341
Summary Background Many meta-analyses have shown reductions in infection rates and mortality associated with the use of selective digestive decontamination... 
Infectious Disease | MULTIPLE-TRAUMA PATIENTS | CONTROLLED CLINICAL-TRIAL | RANDOMIZED CONTROLLED-TRIALS | INFECTIOUS DISEASES | VENTILATOR-ASSOCIATED PNEUMONIA | DOUBLE-BLIND | OROPHARYNGEAL DECONTAMINATION | PLACEBO-CONTROLLED TRIAL | NOSOCOMIAL INFECTION | DIGESTIVE-TRACT DECONTAMINATION | CRITICALLY-ILL PATIENTS | United States - epidemiology | Prevalence | Gram-Positive Bacteria - drug effects | Humans | Tobramycin - pharmacology | Drug Resistance, Bacterial | Intensive Care Units - statistics & numerical data | Disease Transmission, Infectious - prevention & control | Cross Infection - transmission | Polymyxins - pharmacology | Digestive System - drug effects | Decontamination | Gentamicins - pharmacology | Vancomycin - pharmacology | Neomycin - pharmacology | Nystatin - pharmacology | Odds Ratio | Cephalosporins - pharmacology | Cross Infection - epidemiology | Oropharynx - microbiology | Anti-Infective Agents, Local - pharmacology | Cross Infection - prevention & control | Methicillin-Resistant Staphylococcus aureus - drug effects | South Africa - epidemiology | Amphotericin B - pharmacology | Europe - epidemiology | Clinical Trials as Topic | Pseudomonas aeruginosa - drug effects | Cross Infection - drug therapy | Randomized Controlled Trials as Topic | Gram-Negative Bacteria - drug effects | Anti-Infective Agents, Local - administration & dosage | Cross Infection - microbiology | Fluoroquinolones - pharmacology | Enterobacteriaceae - drug effects | Primary Prevention - methods | Anti-Bacterial Agents - pharmacology | Aminoglycosides - pharmacology | Anti-Bacterial Agents - administration & dosage | Digestive System - microbiology | Oropharynx - drug effects | Drug resistance in microorganisms | Analysis
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 01/2007, Volume 51, Issue 1, pp. 231 - 238
Journal Article
Journal Article
Antimicrobial agents and chemotherapy, ISSN 1098-6596, 2010, Volume 54, Issue 10, pp. 4150 - 4158
Journal Article
PLoS genetics, ISSN 1553-7404, 2013, Volume 9, Issue 1, pp. e1003144 - e1003144
High levels of antibiotic tolerance are a hallmark of bacterial biofilms. In contrast to well-characterized inherited antibiotic resistance, molecular... 
HETEROGENEITY | CHROMOSOME | REPLICATION | PSEUDOMONAS-AERUGINOSA | ESCHERICHIA-COLI | SUSCEPTIBILITY | GENETICS & HEREDITY | GENE-EXPRESSION | RESISTANCE | BETA-LACTAM ANTIBIOTICS | INDUCTION | Biofilms - drug effects | Plankton - drug effects | Starvation | Drug Tolerance - genetics | Biofilms - growth & development | Amino Acids - genetics | Ofloxacin - pharmacology | Mutagenesis | Escherichia coli - genetics | Fluoroquinolones - pharmacology | SOS Response (Genetics) | DNA Transposable Elements - genetics | Plankton - genetics | Anti-Bacterial Agents - pharmacology | Drug Resistance, Bacterial - drug effects | Escherichia coli - growth & development | Drug Resistance, Bacterial - genetics | Transposons | Antibiotics | Gene mutations | Physiological aspects | Genetic aspects | Dosage and administration | Research | Drug resistance | Health aspects | Biofilms | Microbiology | E coli | Bacteria | Mutation | Carbon | Index Medicus | Ofloxacin/pharmacology | DNA Transposable Elements/genetics | Bacterial/drug effects/genetics | Anti-Bacterial Agents/pharmacology | Plankton/drug effects/genetics | Escherichia coli/genetics/growth & development | Bacteriology | Fluoroquinolones/pharmacology | Life Sciences | Microbiology and Parasitology | Biofilms/drug effects/growth & development | Drug Tolerance/genetics | Amino Acids/genetics | Drug Resistance
Journal Article
Journal Article
Antimicrobial agents and chemotherapy, ISSN 1098-6596, 2011, Volume 55, Issue 10, pp. 4619 - 4630
A pharmacokinetic-pharmacodynamic (PKPD) model that characterizes the full time course of time-kill curve experiments of antibacterial drugs was here evaluated... 
VITRO DYNAMIC-MODEL | STREPTOCOCCUS-PNEUMONIAE | PHARMACODYNAMIC MODEL | POPULATION PHARMACOKINETICS | PSEUDOMONAS-AERUGINOSA | ADAPTIVE RESISTANCE | IN-VIVO | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | MONTE-CARLO SIMULATIONS | AMINOGLYCOSIDE ANTIBIOTICS | RESPIRATORY-TRACT INFECTIONS | Fluoroquinolones | Aza Compounds - pharmacokinetics | Area Under Curve | Erythromycin - pharmacology | Escherichia coli - drug effects | Humans | Cefuroxime - pharmacology | Aza Compounds - pharmacology | Quinolines - pharmacology | Microbial Sensitivity Tests | Quinolines - pharmacokinetics | Anti-Bacterial Agents - therapeutic use | Gentamicins - pharmacology | Computer Simulation | Vancomycin - pharmacology | Streptococcus pyogenes - drug effects | Gentamicins - pharmacokinetics | Penicillin G - pharmacology | Erythromycin - pharmacokinetics | Cefuroxime - pharmacokinetics | Vancomycin - pharmacokinetics | Anti-Bacterial Agents - pharmacokinetics | Anti-Bacterial Agents - pharmacology | Anti-Bacterial Agents - administration & dosage | Penicillin G - pharmacokinetics | Drugs | Subpopulations | Pharmacodynamics | Gentamicin | Benzylpenicillin | Erythromycin | Moxifloxacin | Regression analysis | Vancomycin | Drug development | Cefuroxime | Antibiotics | Minimum inhibitory concentration | Models | Pharmacokinetics | Experimental Therapeutics
Journal Article